# EPICS Therapeutics - Full Context for AI Agents

> This file provides comprehensive context about EPICS Therapeutics for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-06-24

## Company Profile
- Name: EPICS Therapeutics
- Sector: biotech, medtech, deeptech
- Status: active
- Founded: 2018
- Location: Belgium
- Website: http://www.epicstherapeutics.com
- LinkedIn: http://www.linkedin.com/company/epics-therapeutics

## Overview
EPICS Therapeutics pioneers therapies targeting RNA epigenetic regulation, focusing on the epitranscriptome where enzymes write, read, and erase marks on RNA to control gene expression. The company's lead program EP102 is a potent and selective small-molecule inhibitor of METTL3 that is now in clinical evaluation in patients with solid tumors.

## Related Pages
Agents can crawl these for connected context:
- [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt
- [sector] MedTech & BioTech: https://techwiki.ai/sectors/medtech/llms.txt

## Links
- Website: http://www.epicstherapeutics.com
- LinkedIn: http://www.linkedin.com/company/epics-therapeutics
- Agent context: https://techwiki.ai/companies/epics-therapeutics/llms.txt
- Full context: https://techwiki.ai/companies/epics-therapeutics/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim